Irritable Bowel Syndrome Treatment Market Progressing At A CAGR Of 10.1% For The Forecast Period From 2019 To 2026 : Grand View Research Inc.
San Francisco, 9 August 2019: The Report Irritable Bowel Syndrome Treatment Market Size, Share & Analysis Report By Type (IBS-C, IBS-D), By Product (Xifaxan, Linzess/Constella, Viberzi, Amitiza), By Region, And Segment Forecasts, 2019 – 2026 The global irritable bowel syndrome treatment market size is expected to reach USD 3.3 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a 10.1% CAGR during the forecast period. Rising prevalence of target disease and increasing label extension of existing drugs are likely to accelerate market growth. In addition, growing uptake of drugs and launch of novel products are anticipated to drive the irritable bowel syndrome (IBS) treatment market. IBS is one of the most common gastrointestinal disorders, with the worldwide prevalence rate usually ranging between 10-15%. Most of the patients with IBS are under 50 years of age but many older adults suffer as well. The effect of the condition can vary from mi